Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance
Chi Zhang, Chaoying Qin, Saikat Dewanjee, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 35
Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy
Puja Sandbhor, Pranoti Palkar, Sakshi Bhat, et al.
Nanoscale (2024) Vol. 16, Iss. 13, pp. 6330-6364
Closed Access | Times Cited: 14
Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy
Yiwei Zhang, Yujun Zhang, Jingjing Song, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111876-111876
Closed Access | Times Cited: 9
Adrenergic microenvironment driven by cancer‐associated Schwann cells contributes to chemoresistance in patients with lung cancer
Yusuke Otani, Haruyoshi Katayama, Yidan Zhu, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2333-2345
Open Access | Times Cited: 8
Tumor Microenvironment as a Target for Developing Anticancer Hydrogels
Suman Khurana, Shrestha Sharma, Parveen Kumar Goyal
Drug Development and Industrial Pharmacy (2025), pp. 1-20
Closed Access | Times Cited: 1
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Targeting Cancer Stemness Using Nanotechnology in a Holistic Approach: A Narrative Review
Melinda-Ildiko Mitranovici, Laura Caravia, Liviu Moraru, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 277-277
Open Access | Times Cited: 1
Understanding cancer stem cells and plasticity: Towards better therapeutics
Neerada Meenakshi Warrier, Nachiket Kelkar, Carol Tresa Johnson, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 2, pp. 151321-151321
Open Access | Times Cited: 20
Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting
Qianqian Guo, Yi Zhou, Tianyuan Xie, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101043-101043
Open Access | Times Cited: 17
Unique therapeutic potentialities of exosomes based nanodrug carriers to target tumor microenvironment in cancer therapy
Safir Ullah Khan, Munir Ullah Khan, Y. Gao, et al.
OpenNano (2022) Vol. 8, pp. 100091-100091
Open Access | Times Cited: 21
Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights
Pratikshya Sa, Priyanka Mohapatra, Shasank S. Swain, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 11, pp. 5254-5277
Closed Access | Times Cited: 11
Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier
Aadya Nayak, Neerada Meenakshi Warrier, Rachana Raman, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105980-105980
Open Access | Times Cited: 4
In Vitro models of leukemia development: the role of very small leukemic stem-like cells in the cellular transformation cascade
Jan Jakub Lica, Joanna Jakóbkiewicz‐Banecka, Andrzej Hellmann
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Methylmalonic acid at the serum level in the elderly contributes to cell growth via mitochondrial dysfunction in colorectal cancer cell spheroids
Arowu R. Tanaka, Chiho Murakami, Hideya Yamamoto
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101909-101909
Closed Access
Inhibition of lysosomal TRPML1 channel eliminates breast cancer stem cells by triggering ferroptosis
Chunhong Fan, Haotian Wu, Xin Du, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma
Sachindra Kumar, Dube Aakash Arwind, Harish Kumar B, et al.
Translational Oncology (2024) Vol. 46, pp. 102023-102023
Open Access | Times Cited: 3
Targeting Triple‐Negative Breast Cancer: Resistance Mechanisms and Therapeutic Advancements
Rachana Raman, Shristi Debata, Thirupugal Govindarajan, et al.
Cancer Medicine (2025) Vol. 14, Iss. 9
Open Access
Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination
Sumon Mukherjee, Sourio Chakraborty, Udit Basak, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies
Cristina Ferreira Almeida, Georgina Correia‐da‐Silva, Natércia Teixeira, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116178-116178
Open Access | Times Cited: 2
QiDongNing induces lung cancer cell apoptosis via triggering P53/DRP1‐mediated mitochondrial fission
Rongzhen Ding, Yichao Wang, Ling Xu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 9
Open Access | Times Cited: 2
Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies
Xintong Peng, Jingfan Zheng, Tianzi Liu, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 288-307
Closed Access | Times Cited: 4
Cancer Stem Cells: Robust Features and Therapeutic Targets
Marwa M. Abu‐Serie, Eman Sarhan
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Wnt signaling in the tumor microenvironment: A driver of brain tumor dynamics
Han Na Suh, Gee Euhn Choi
Life Sciences (2024), pp. 123174-123174
Open Access | Times Cited: 1
Hypoxia, Stem Cells and Cancer Stem Cells
Mostafa Manian, Marjan Taherian, Hamid Nickho, et al.
Stem cell biology and regenerative medicine (2024), pp. 29-114
Closed Access | Times Cited: 1
Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?
Francesco Pasqualetti, Mario Miniati, Alessandra Gonnelli, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1295-1295
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top